Clinical and immunohistochemical studies were done for 3-39 d on mice after intracerebral inoculation with the neurovirulent A/WSN/33 (H1N1; WSN) strain of influenza A virus, the nonneurovirulent A/Aichi/2/68 (H3N2; Aichi) strain, and two reassortant viruses between them. The virus strains with the WSN gene segment coding for neuraminidase induced meningoencephalitis in mice. The mice inoculated with the R96 strain, which has only the neuraminidase gene from the WSN strain, had mild symptoms and weak positive immunostaining to the anti-WSN antibody in meningeal regions. Both the WSN and R404BP strains, which contain the WSN gene segments coding for neuraminidase and matrix protein, were clearly neurovirulent both clinically and pathologically. On day 3 after inoculation with either of these two strains, WSN antigen was detected in meningeal and ependymal areas, neurons of circumventricular regions, the cerebral and cerebellar cortices, the substantia nigra zona compacta, and the ventral tegmental area. On day 7, meningeal reactions and neuronal staining were still seen, and advanced accumulation of the viral antigen was evident in the substantia nigra zona compacta and hippocampus. Double immunostaining demonstrated that the WSN antigen was only seen in neurons and not in microglia or reactive astrocytes. Immunostaining for the lectin maackia amurensis agglutinin, which recognizes the Neu5Ac alpha 2,3 Gal sequence, which serves as a binding site for influenza A virus on target cell membranes, showed that positive staining was localized in the ventral substantia nigra and hippocampus. These results suggest that neurovirulent influenza A viruses could be one of the causative agents for postencephalitic parkinsonism.
Skip Nav Destination
Article navigation
1 June 1995
Article|
June 01 1995
The substantia nigra is a major target for neurovirulent influenza A virus.
M Takahashi,
M Takahashi
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
Search for other works by this author on:
T Yamada,
T Yamada
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
Search for other works by this author on:
S Nakajima,
S Nakajima
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
Search for other works by this author on:
K Nakajima,
K Nakajima
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
Search for other works by this author on:
T Yamamoto,
T Yamamoto
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
Search for other works by this author on:
H Okada
H Okada
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
Search for other works by this author on:
M Takahashi
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
T Yamada
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
S Nakajima
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
K Nakajima
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
T Yamamoto
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
H Okada
Choju Medical Institute, Noyori Fukushi-mura Hospital, Toyohashi, Japan.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1995) 181 (6): 2161–2169.
Citation
M Takahashi, T Yamada, S Nakajima, K Nakajima, T Yamamoto, H Okada; The substantia nigra is a major target for neurovirulent influenza A virus.. J Exp Med 1 June 1995; 181 (6): 2161–2169. doi: https://doi.org/10.1084/jem.181.6.2161
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement